Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
“We are delivering on our promise to make sure women have accurate, scientifically grounded information about the potentially life-changing benefits of HRT.” — FDA Commissioner Marty Makary, MD, MPH
Obstetrics & Gynecology February 24th 2026
Specialty Pharmacy Continuum
As pharmacists, it’s crucial to note that, although these changes in FDA guidelines may not directly impact your practice, they signify a shift in how biosimilars will be identified moving forward. This could potentially influence how you advise patients about these products.
Clinical Pharmacology October 30th 2023